Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Prometheus Labs and UCLA study biological markers of mucosal healing in IBD

Dec. 13, 2010

Apexigen and Centocor to collaborate on antibody discovery

Dec. 13, 2010

Baylor Research Institute and Roche partner for immunology research

Dec. 10, 2010

Ascenta and LLS collaborate to develop AT-406

Dec. 10, 2010

Cephalon and Mesoblast join to develop mesenchymal precursor stem cell therapies

Dec. 10, 2010

Theratechnologies and sanofi-aventis enter agreement for Egrifta

Dec. 9, 2010

Sangart and U.S. navy join to develop MP4 to treat traumatic brain injury

Dec. 9, 2010

Case Western Reserve University licenses insulin analogues to Thermalin Diabetes

Dec. 7, 2010

The Leukemia and Lymphoma Society provides support to BioTheryX

Dec. 7, 2010

Ascenta Therapeutics and Ascentage Pharma form alliance for cancer programs

Dec. 3, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...